Your browser doesn't support javascript.
loading
Publisher Correction: B cell therapy in ANCA-associated vasculitis: current and emerging treatment options.
McClure, Mark; Gopaluni, Seerapani; Jayne, David; Jones, Rachel.
Afiliación
  • McClure M; Vasculitis and Lupus Clinic, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, UK.
  • Gopaluni S; Vasculitis and Lupus Clinic, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, UK.
  • Jayne D; Vasculitis and Lupus Clinic, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, UK. dj106@cam.ac.uk.
  • Jones R; Vasculitis and Lupus Clinic, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, UK.
Nat Rev Rheumatol ; 14(12): 741, 2018 Dec.
Article en En | MEDLINE | ID: mdl-30390047
ABSTRACT
In the section 'Combining B cell-targeted therapies' in the originally published version of this article, the 24-week interim analysis for the CALIBRATE study was incorrectly given as the 2- to 4-week interim analysis. This error has now been corrected in the HTML and PDF versions of the manuscript.
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Nat Rev Rheumatol Asunto de la revista: REUMATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Nat Rev Rheumatol Asunto de la revista: REUMATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido